Child Psychiatry & Human Development

, Volume 42, Issue 4, pp 424–441 | Cite as

Still Struggling: Characteristics of Youth With OCD Who are Partial Responders to Medication Treatment

  • J. Freeman
  • J. Sapyta
  • A. Garcia
  • D. Fitzgerald
  • M. Khanna
  • M. Choate-Summers
  • P. Moore
  • A. Chrisman
  • N. Haff
  • A. Naeem
  • J. March
  • M. Franklin
Original Article


The primary aim of this paper is to examine the characteristics of a large sample of youth with OCD who are partial responders (i.e., still have clinically significant symptoms) to serotonin reuptake inhibitor (SRI) medication. The sample will be described with regard to: demographics, treatment history, OCD symptoms/severity, family history and parental psychopathology, comorbidity, and global and family functioning. The sample includes 124 youth with OCD ranging in age from 7 to 17 with a primary diagnosis of OCD and a partial response to an SRI medication. The youth are a predominantly older (age 12 and over), Caucasian, middle to upper income group who had received significant past treatment. Key findings include moderate to severe OCD symptoms, high ratings of global impairment, and significant comorbidity, despite partial response to an adequate medication trial. Considerations regarding generalizability of the sample and limitations of the study are discussed.


Pediatric obsessive compulsive disorder (OCD) Serotonin reuptake inhibitor (SRI) Partial responder Phenomenology 


  1. 1.
    Mullick M, Goodman R (2005) The prevalence of psychiatric disorders in 5–10 year olds in rural, urban and slum areas in Bangladesh. Soc Psychiatry Psychiatr Epidemiol 40:663–671PubMedCrossRefGoogle Scholar
  2. 2.
    Valleni-Basile LA, Garrison CZ, Jackson KL, Waller JL, McKeown RE, Addy CL et al (1995) Frequency of obsessive-compulsive disorder in a community sample of young adolescents. J Am Acad Child Adol Psychiatry 34:128–129CrossRefGoogle Scholar
  3. 3.
    Flament MF, Koby E, Rapoport JL, Berg CJ, Zahn T, Cox C et al (1990) Childhood obsessive-compulsive disorder: a prospective follow-up study. J Child Psychol Psychiatry 31:363–380PubMedCrossRefGoogle Scholar
  4. 4.
    Leonard HL, Lenane M, Swedo SE (1993) Obsessive-compulsive disorder. Child Adolesc Psychiatr Clin N Am 2:655–665Google Scholar
  5. 5.
    Swedo SE, Rapoport JL, Leonard HL, Lenane M, Cheslow D (1989) Obsessive compulsive disorders in children and adolescents: clinical phenomenology of 70 consecutive cases. Arch Gen Psychiatry 46:335–343PubMedGoogle Scholar
  6. 6.
    Piacentini J, Bergman RL, Keller M, McCracken J (2003) Functional impairment in children and adolescents with obsessive-compulsive disorder. J Child Adolesc Psychopharmacol 13:S61–S69PubMedCrossRefGoogle Scholar
  7. 7.
    Rasmussen SA, Eisen J (1992) The epidemiology and differential diagnosis of obsessive compulsive disorder. J Clin Psychiatry 53:4–10PubMedGoogle Scholar
  8. 8.
    Pediatric OCD Treatment Study Team [POTS] (2004) Cognitive-behavior therapy, sertraline, and their combination with children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA 292:1969–1976CrossRefGoogle Scholar
  9. 9.
    King RA, Leonard HL, March J (1998) Practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 37:27S–45SCrossRefGoogle Scholar
  10. 10.
    March JS, Frances A, Carpenter D, Kahn DA, Foa EB, Greist JH et al (1997) Treatment of obsessive-compulsive disorder. J Clin Psychiatry 58:2–72Google Scholar
  11. 11.
    Cartwright C, Hollander E (1998) SSRIs in the treatment of obsessive-compulsive disorder. Depress Anxiety 8:105–113PubMedCrossRefGoogle Scholar
  12. 12.
    Rushton JL, Whitmore JT (2001) Pediatric stimulant and selective serotonin reuptake inhibitor prescription trends: 1992 to 1998. Arch Pediatr Adolesc Med 155:560–565PubMedGoogle Scholar
  13. 13.
    Freeman J, Choate-Summers M, Garcia A, Moore P, Sapyta J, Khanna M et al (2009) The pediatric obsessive-compulsive disorder treatment study II: rationale, design and methods. Child Adolesc Psychiatr Ment Health 3:4CrossRefGoogle Scholar
  14. 14.
    Franklin M, Sapyta J, Freeman J, Khanna M, Compton S, Almirall D et al. (2011) Cognitive-behavior therapy augmentation of pharmacotherapy in pediatric obsessive compulsive disorder: the pediatric OCD treatment study II (POTS II) randomized, controlled trial. JAMA (under review)Google Scholar
  15. 15.
    March JS, Biederman J, Wolkow R, Safferman A, Mardekian J, Cook EH et al (1998) Sertraline in children and adolescents with obsessive-compulsive disorder: A multicenter randomized controlled trial. JAMA 280:1752–1756PubMedCrossRefGoogle Scholar
  16. 16.
    Riddle MA, Scahill L, King RA, Hardin MT, Anderson GM, Ort SI et al (1992) Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 31:1062–1069PubMedCrossRefGoogle Scholar
  17. 17.
    Liebowitz MR, Turner S, Piacentini J, Beidel D, Clarvit SR, Davies SO et al (2002) Fluoxetine in children and adolescents with OCD: a placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 41:1431–1438PubMedCrossRefGoogle Scholar
  18. 18.
    Riddle MA, Reeve EA, Yaryura-Tobias JA, Yang HM, Claghorn JL, Gaffney G et al (2001) Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial. J Am Acad Child Adolesc Psychiatry 40:222–229PubMedCrossRefGoogle Scholar
  19. 19.
    Rosenberg DR, Stewart CM, Fitzgerald KD, Tawile V, Carroll E (1999) Paroxetine open-label treatment of pediatric outpatients with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 38:1180–1185PubMedCrossRefGoogle Scholar
  20. 20.
    de Haan E, Hoogduin KA, Buitelaar JK, Keijsers GP (1998) Behavior therapy versus clomipramine for the treatment of obsessive-compulsive disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry 37:1022–1029PubMedCrossRefGoogle Scholar
  21. 21.
    DeVeaugh-Geiss J, Moroz G, Biederman J, Cantwell DP, Fontaine R, Greist JH et al (1992) Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder–a multicenter trial. J Am Acad Child Adolesc Psychiatry 31:45–49PubMedCrossRefGoogle Scholar
  22. 22.
    Leonard HL, Swedo SE, Rapoport JL, Koby EV, Lenane MC, Cheslow DL et al (1989) Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. Arch Gen Psychiatry 46:1088–1092PubMedGoogle Scholar
  23. 23.
    Hollander E, Allen A, Steiner M, Wheadon DE, Oakes R, Burnham DB (2003) Acute and long-term treatment and prevention of relapse of obsessive-compulsive disorder with paroxetine. J Clin Psychiatry 64:1113–1121PubMedCrossRefGoogle Scholar
  24. 24.
    Silverman WK, Albano AM (1996) Anxiety disorders interview schedule for DSM-IV. The Psychological Corporation, San AntonioGoogle Scholar
  25. 25.
    Silverman WK, Saavedra LM, Pina AA (2001) Test-retest reliability of anxiety symptoms and diagnoses with anxiety disorders interview schedule for DSM-IV: child and parent versions. J Am Acad Child Adolesc Psychiatry 40:937–944PubMedCrossRefGoogle Scholar
  26. 26.
    Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J et al (1989) The Yale global tic severity scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 28:566–573PubMedCrossRefGoogle Scholar
  27. 27.
    Kovacs M (1992) Children’s depression inventory manual. Multi-Health Systems, Inc, North TonawandaGoogle Scholar
  28. 28.
    March JS, Parker J, Sullivan K, Stallings P, Conners K (1997) The multidimensional anxiety scale for children MASC. J Am Acad Child Adolesc Psychiatry 36:554–565PubMedCrossRefGoogle Scholar
  29. 29.
    March J (1997) Multidimensional anxiety scale for children. Multi-Health Systems Inc, North TonawandaGoogle Scholar
  30. 30.
    Conners CK (1997) Conners’ rating scales-revised: instruments for use with children and adolescents. Multi-Health Systems, North TonawandaGoogle Scholar
  31. 31.
    Conners CK, Sitarenios G, Parker J, Epstein J (1998) The revised Conners’ parent rating scale: factor structure, reliability, and criterion validity. J Abnorm Child Psychol 26:257–268PubMedCrossRefGoogle Scholar
  32. 32.
    Conners CK (1994) Conners-March developmental questionnaire. Multi-Health Systems, Inc, North TonawandaGoogle Scholar
  33. 33.
    Derogatis L, Melisaratos N (1983) The brief symptom inventory: an introductory report. Psychol Med 13:595–605PubMedCrossRefGoogle Scholar
  34. 34.
    Scahill L, Riddle MA, McSwiggan-Hardin M, Ort SI, King RA, Goodman WK et al (1997) Children’s Yale-Brown obsessive-compulsive scale: reliability and validity. J Am Acad Child Adolesc Psychiatry 36:844–852PubMedCrossRefGoogle Scholar
  35. 35.
    National Institute of Mental Health (1985) Clinical global impressions. Psychopharmacol Bull 21:839–843Google Scholar
  36. 36.
    Garvey MA, Perlmutter SJ, Allen AJ, Hamburger S, Lougee L, Leonard HL et al (1999) A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol Psychiatry 45:1564–1571PubMedCrossRefGoogle Scholar
  37. 37.
    Perlmutter SJ, Leitman SF, Garvey MA, Hamburger S, Feldman E, Leonard HL (1999) Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 354:1153–1158PubMedCrossRefGoogle Scholar
  38. 38.
    Goodman WK, Price LH (1992) Assessment of severity and change in obsessive compulsive disorder. Pediatr Clin N Am 15:861–869Google Scholar
  39. 39.
    Piacentini J (2006) Scoring manual for the child OC impact scale (COIS). Unpublished manuscriptGoogle Scholar
  40. 40.
    Green B, Shirk S, Hanze D, Wanstrath J (1994) The children’s global assessment scale in clinical practice: an empirical evaluation. J Am Acad Child Adolesc Psychiatry 33:1158–1164PubMedCrossRefGoogle Scholar
  41. 41.
    Bird HR, Canino GJ, Rubio-Stipec M, Ribera JC (1987) Further measures of the psychometric properties of the children’s global assessment scale. Arch Gen Psychiatry 44:821–824PubMedGoogle Scholar
  42. 42.
    Endicott J, Nee J, Yang R, Wohlberg C (2006) Pediatric quality of life, enjoyment and satisfaction questionnaire (PQ-LES-Q): reliability and validity. J Am Acad Child Adolesc Psychiatry 45:401–407PubMedCrossRefGoogle Scholar
  43. 43.
    Skinner HA, Steinhauer PD, Santa-Barbara J (1995) Family assessment measure-III manual. Multi Health Systems, TorontoGoogle Scholar
  44. 44.
    Skinner HA, Steinhauer PD, Santa-Barbara J (1983) The family assessment measure. Can J Commun Ment Health 2:91–105Google Scholar
  45. 45.
    Skinner HA, Steinhauer PD, Santa-Barbara J (1984) Family assessment measure-general scale. Multi Health Systems, TorontoGoogle Scholar
  46. 46.
    Steinhauer PD, Santa-Barbara J, Skinner HA (1984) The process model of family functioning. Can J Psychiatry 29:77–88PubMedGoogle Scholar
  47. 47.
    Barrett P, Healy-Farrell L, March JS (2004) Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial. J Am Acad Child Adolesc Psychiatry 43:46–62PubMedCrossRefGoogle Scholar
  48. 48.
    Storch E, Geffken G, Merlo L (2007) Family-based cognitive-behavioral therapy for pediatric obsessive-compulsive disorder: comparison of intensive and weekly approaches. J Am Acad Child Adolesc Psychiatry 46:469–478PubMedCrossRefGoogle Scholar
  49. 49.
    Fireman B, Koran LM, Leventhal JL, Jacobson A (2001) The prevalence of clinically recognized obsessive-compulsive disorder in a large health maintenance organization. Am J Psychiatry 158:1904–1910PubMedCrossRefGoogle Scholar
  50. 50.
    Masi G, Millepiedi S, Mucci M, Bertini N, Milantoni L, Arcangeli F (2005) A naturalistic study of referred children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 44:673–681PubMedCrossRefGoogle Scholar
  51. 51.
    Breton J, Bergeron L, Valla JP, Berthiaume C, Gaudet N, Lambert J et al (1999) Quebec children mental health survey: prevalence of DSM-III-R mental health disorders. J Child Psychol Psychiatry 40:375–384PubMedCrossRefGoogle Scholar
  52. 52.
    DuPaul GJ, Power TJ, Anastopoulos AD, Reid R (1999) The ADHD rating scale-IV: checklists, norms, and clinical interpretation. Guilford, New YorkGoogle Scholar
  53. 53.
    Abramowitz JS, Whiteside SP, Deacon BJ (2005) The effectiveness of treatment for pediatric obsessive-compulsive disorder: a meta-analysis. Behavior Therapy 36:55–63CrossRefGoogle Scholar
  54. 54.
    Ackerman DL, Greenland S (2002) Multivariate meta-analysis of controlled drug studies for obsessive-compulsive disorder. J Clin Psychopharmacol 22:309–317PubMedCrossRefGoogle Scholar
  55. 55.
    Williams M, Powers M, Yun Y, Foa E (2010) Minority participation in randomized controlled trials for obsessive-compulsive disorder. J Anxiety Disord 24:171–177PubMedCrossRefGoogle Scholar
  56. 56.
    Hankin CS, Koran LM, Bronstone A, Black DW, Sheehan DV, Hollander E et al (2009) Adequacy of pharmacotherapy among Medicaid-enrolled patients newly diagnosed with OCD. CNS Spectrums 14:695–703PubMedGoogle Scholar
  57. 57.
    Rue DSX Y (2009) Disparities in treating culturally diverse children and adolescents. Psychiatr Clin N Am 32:153–163CrossRefGoogle Scholar
  58. 58.
    Paradis CM, Lazar RM, Grubea J, Kesselman M (1992) Panic disorder in an inner-city psychiatric outpatient department: results of a structured interview. Hosp Community Psychiatry 43:61–64PubMedGoogle Scholar
  59. 59.
    Friedman S, Smith LC, Halpern B, Levine C, Paradis C, Viswanathan R et al (2003) Obsessive compulsive disorder in a multi-ethnic urban outpatient clinic: initial presentation and treatment outcome with exposure and ritual prevention. Behavior Therapy 34:397–410CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • J. Freeman
    • 1
    • 2
    • 3
  • J. Sapyta
    • 4
  • A. Garcia
    • 1
  • D. Fitzgerald
    • 4
  • M. Khanna
    • 5
  • M. Choate-Summers
    • 1
  • P. Moore
    • 6
  • A. Chrisman
    • 4
  • N. Haff
    • 1
  • A. Naeem
    • 7
  • J. March
    • 4
  • M. Franklin
    • 5
  1. 1.Department of Psychiatry and Human BehaviorAlpert Medical School of Brown UniversityProvidenceUSA
  2. 2.Division of Child and Adolescent Psychiatry, Rhode Island Hospital and Bradley/Hasbro Children’s Research CenterProvidenceUSA
  3. 3.Pediatric Anxiety Research Clinic, Rhode Island Hospital and Bradley/Hasbro Children’s Research CenterProvidenceUSA
  4. 4.Duke University School of MedicineDurhamUSA
  5. 5.University of Pennsylvania School of MedicinePhiladelphiaUSA
  6. 6.University of Massachusetts Medical SchoolWorcesterUSA
  7. 7.The Children’s Hospital of PhiladelphiaPhiladelphiaUSA

Personalised recommendations